SUPER
  1. Home
  2. Stocks
  3. FEROZ
  4. News and notes

FEROZ · PHARMACEUTICALS

FEROZ news and notes Ferozsons Laboratories Limited

Ferozsons Laboratories Limited (FEROZ) news and notes: the SuperX note and what changed (5 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.

What SuperX wrote about FEROZ

  1. On 29 Oct the price rose 6.35% on 10.23 times the usual volume. Results were filed that day.

  2. The half-year period ends 31 Dec. Last year the company filed its half-year results on 26 Feb.

  3. Latest quarter EPS was 5.05, up 20.24% on the year-ago 4.2. The price is 362.49, down 1.49% today.

Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.

What changed for FEROZ, newest first

  • 13 Nov 2026Closed 362.49, -1.49%. Volume 1,769, 0.2 times the average of the 30 sessions before it, 9,652.
  • 6 Nov 2026Trend read changed to leaning up: above the 50-day average, below the 200-day; up 10.5% over 1 month.
  • 31 Oct 2026Fund reports for October: 1 fund line prints FEROZ in its top ten, from 1 of the 21 fund managers known.
  • 29 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 5.05, sales Rs 4.8 bn, up 20.2% on the same quarter a year before.
  • NextHalf-year results (to 31 Dec 2026) expected 30 Jan 2027 – 27 Mar 2027, a projection. An estimate from the dates of the last 8 filings.

As of the close of 13 Nov 2026. Closes and notices: PSX. Funds: the managers’ monthly reports, an estimate. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 8 filings. Not advice.

More on FEROZ

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .